despit
long
postul
compel
evid
theori
microbi
trigger
drive
autoimmun
recent
report
specif
associ
novosphingobium
aromaticivoran
ubiquit
alphaproteobacterium
primari
biliari
cirrhosi
pbc
uncov
patient
pbc
notabl
associ
novosphingobium
infect
pbc
confirm
mous
model
infect
lead
develop
liver
lesion
resembl
pbc
concomit
product
antibodi
crossreact
conserv
epitop
share
novosphingobium
discoveri
infecti
trigger
autoimmun
like
chang
current
concept
etiolog
variou
autoimmun
syndrom
may
suggest
new
simpler
way
diagnos
treat
debilit
diseas
alphaproteobacteria
antibiot
autoimmun
subunit
pyruv
dehydrogenas
complex
mitochondri
enzym
molecular
mimicri
novosphingobium
spp
primari
biliari
cirrhosi
underli
etiolog
autoimmun
diseas
difficult
elucid
driven
complex
interact
environment
factor
genet
trait
although
autoimmun
often
cluster
togeth
individu
famili
indic
potenti
broadspectrum
genet
defect
immunolog
toler
mechan
genet
factor
lead
develop
immun
respons
specif
antigen
tissu
andor
organspecif
manner
remain
larg
unknown
compartment
autoimmun
respons
particularli
surpris
mani
autoantigen
ubiquit
express
although
mani
environment
factor
associ
develop
autoimmun
diseas
infecti
agent
long
consid
potenti
culprit
induct
disord
exampl
rheumat
fever
repres
one
prototyp
autoimmun
diseas
infecti
origin
clinic
practic
welldocu
exampl
includ
autoimmun
gastriti
syndrom
summar
tabl
despit
exampl
establish
strong
associ
specif
microbi
infect
develop
autoimmun
diseas
patient
remain
challeng
infectioninduc
model
autoimmun
disord
involv
either
induct
nonspecif
inflamm
ectop
express
selfantigen
microb
andor
host
tissu
anim
shed
light
potenti
role
infect
develop
autoimmun
diseas
led
evolut
follow
gener
concept
induct
autoimmun
microbi
infect
enhanc
present
selfantigen
due
pathogeninduc
inflamm
activ
autoreact
lymphocyt
requir
diseas
induct
tissu
damag
caus
microb
result
releas
sequest
selfantigen
activ
autoreact
cell
demonstr
autoimmun
diabet
trigger
coxsackieviru
infect
mice
inflamm
elicit
microb
promot
dendrit
cell
matur
follow
upregul
mhc
complex
cytokin
secret
promot
tcell
activ
epitopeautoimmun
spread
well
document
murin
model
encephalomyel
one
caveat
theori
although
signatur
autoantigen
certain
autoimmun
diseas
exist
read
pleas
see
unclear
whether
autoantigen
involv
whether
suffici
target
antigen
induc
diseas
alon
altern
model
suggest
follow
chronic
exposur
microbi
infect
serial
breakdown
toler
multipl
selfantigen
expos
tissu
inflamm
destruct
may
requir
full
diseas
induct
last
pathogen
might
express
antigen
epitop
structur
relat
epitop
autoantigen
result
molecular
mimicri
box
concept
initi
establish
experiment
model
autoimmun
encephalomyel
trigger
hbv
polymeras
peptid
may
appli
syndrom
mediat
antilipopolysaccharid
antibodi
campylobact
jejuni
crossreact
human
gangliosid
rheumat
fever
caus
antistreptococc
immun
respons
crossreact
cardiac
myosin
possibl
latephas
lyme
diseas
similar
mechan
may
associ
helicobact
pylori
infect
chronic
atrophicautoimmun
gastriti
molecular
mimicri
might
also
play
role
pathogenesi
primari
biliari
cirrhosi
pbc
chronic
cholestat
liver
diseas
support
potenti
role
molecular
mimicri
pathogenesi
pbc
recent
shown
undetect
infect
ubiquit
alphaproteobacterium
novosphingobium
aromaticivoran
strongli
associ
pbc
human
base
clinic
report
begun
studi
mechan
infect
novosphingobium
trigger
autoimmun
propag
autoreact
b
cell
mous
model
resembl
pbc
without
need
ectop
antigen
present
provid
compel
evid
activ
natur
killer
nkt
cell
elicit
due
uniqu
cell
wall
antigen
novosphingobium
explain
liverspecif
patholog
although
potenti
tand
bcell
antigen
subunit
pyruv
dehydrogenas
complex
ubiquit
express
structur
relationship
mammalian
bacteri
structur
may
elicit
crossreact
immun
respons
may
contribut
erad
bacteria
mimic
specif
b
cell
crossreact
selfepitop
thu
lead
tissu
patholog
autoimmun
divisionphylum
proteobacteria
class
alphaproteobacteria
therein
particularli
often
associ
autoimmun
figur
infect
brucella
spp
exampl
report
involv
multipl
organ
system
induc
chronic
inflamm
hepat
immuneinduc
thrombocytopenia
andor
thrombocytopen
purpura
emerg
pathogen
ehrlichia
spp
also
associ
similar
diseas
characterist
although
patholog
mechan
understood
date
diseas
symptom
inflamm
often
persist
even
though
microbi
copi
hardli
recov
respect
tissu
suggest
potenti
autoimmun
compon
elicit
bacteria
phenomenon
also
observ
infect
chaga
lyme
diseas
even
though
multipl
organ
system
involv
liver
often
becom
target
aberr
immun
reaction
infect
alphaproteobacteria
potenti
due
preferenti
persist
microb
organ
site
uniqu
distinct
cellular
composit
predomin
abund
kupffer
cell
kc
natur
killer
nk
cell
nkt
cell
liver
consid
organ
innat
immun
featur
expos
microbi
product
toxic
environment
substanc
food
antigen
due
blood
circul
intestin
play
critic
role
induct
immun
toler
howev
liver
may
involv
mani
system
diseas
becom
target
advers
immun
reaction
put
autoimmun
diseas
pbc
bacteria
andor
bacteri
product
transloc
intestin
liver
may
involv
process
pathogen
mechan
biliari
injuri
pbc
poorli
defin
stimuli
trigger
autoreact
unknown
includ
genet
environment
factor
factor
implic
clinic
uniform
pbc
presenc
highli
specif
serolog
marker
antimitochondri
antibodi
direct
box
subunit
domin
autoreact
bcell
epitop
main
antigen
recogn
liverinfiltr
autoreact
cell
howev
understood
date
mitochondri
antigen
specif
target
immun
reaction
restrict
liver
although
autoantigen
ubiquit
express
tissu
molecular
mimicri
propos
mechan
develop
autoimmun
pbc
environment
factor
implic
pbc
pathogenesi
includ
tobacco
reproduct
hormon
exposur
nail
polish
toxic
wast
xenobiot
repeat
urinari
tract
infect
vaccin
studi
mice
use
acid
induct
histolog
lesion
well
antibodi
provid
argument
favor
environment
origin
human
pbc
induct
diseas
due
molecular
mimicri
bacteria
virus
also
suggest
caus
agent
one
particular
alphaproteobacterium
howev
n
aromaticivoran
stand
greater
homolog
immunodomin
region
human
microorgan
studi
thu
far
primari
biliari
cirrhosi
pbc
chronic
progress
cholestat
diseas
liver
key
patholog
featur
includ
immunemedi
destruct
small
bile
duct
liver
lead
progress
cholestasi
often
endstag
liver
diseas
autoantibodi
bind
subunit
pyruv
dehydrogenas
complex
role
autoantibodi
pathogenesi
pbc
remain
unknown
far
elev
serum
igm
level
hyperigm
syndrom
reflect
anoth
abnorm
humor
immun
system
characterist
pbc
histopatholog
lesion
pbc
present
mix
lymphoidmononuclear
infiltr
around
bile
duct
enhanc
inflammatori
cytokin
profil
level
reduc
addison
gull
describ
clinic
pictur
progress
obstruct
jaundic
absenc
mechan
obstruct
larg
bile
duct
ahren
colleagu
name
diseas
pbc
term
controversi
cirrhosi
develop
late
cours
diseas
n
aromaticivoran
gramneg
bacterium
belong
sphingomonodacea
famili
figur
box
found
ubiquit
environ
human
mucos
surfac
human
fece
strain
sphingomonasnovosphingobium
exhibit
xenobioticmetabol
properti
degrad
wide
varieti
environment
hazard
compound
includ
polycycl
aromat
dioxin
compound
chlorin
phenol
sphingomonasnovosphingobium
spp
preferenti
sphingomona
paucimobili
formerli
pseudomona
paucimobili
implic
varieti
communityacquir
nosocomi
infect
includ
bacteremia
catheterrel
sepsi
mening
periton
pneumonia
cutan
infect
viscer
abscess
urinari
biliari
tract
infect
aden
diarrheal
diseas
lack
typic
lipopolysaccharid
constitu
cellular
membran
sphingomonasnovosphingobium
accompani
defici
endotoxin
activ
may
explain
lack
death
attribut
organ
administr
antibiot
result
resolut
infect
nosocomi
novosphingobium
infect
resist
pseudomona
infect
therefor
combin
therapi
thirdgener
cephalosporin
aminoglycosid
recommend
biochem
identif
glycuronosylceramid
substitut
lipopolysaccharid
origin
made
sphingomona
capsulata
although
presenc
glycolipid
extend
genera
test
far
includ
novosphingobium
aromaticivoran
uniqu
cell
wall
bacteria
elicit
distinct
innat
immun
pathway
may
respons
trigger
liverspecif
patholog
cell
wall
sphingomonodacea
unusu
contain
glycosphingolipid
gsl
instead
lp
nkt
cell
specif
recogn
sphingomonodacea
gsl
absenc
activ
lp
domin
innat
immun
respons
latent
unrecogn
infect
n
aromaticivoran
relat
novosphingobium
sppbacteria
may
therefor
account
increas
nkt
cell
number
may
react
novosphingobium
gsl
suggest
mous
model
see
later
enhanc
express
found
liver
pbc
patient
molecular
mimicri
mitochondri
enzym
phylogenet
relat
antigen
novosphingobium
share
conserv
epitop
suggest
analysi
mitochondri
encod
gene
genom
organizationdistribut
impli
mitochondri
genom
deriv
alphaproteobacterium
like
ancestor
invad
archeatyp
host
billion
year
ago
evolutionari
associ
alphaproteobacteri
mammalian
mitochondri
antigen
might
critic
develop
pbc
target
specif
immun
attack
mitochondri
enzym
target
enzym
subsequ
interfer
metabol
bacterium
may
reflect
ancient
defens
mechan
immun
system
invad
agent
although
know
inner
mitochondri
oxoacid
dehydrogenas
complex
mitochondri
protein
target
autoimmun
assault
sever
diseas
associ
mitochondria
howev
patholog
pattern
evolutionari
relationship
may
broader
impact
translat
well
patient
pbc
express
antibodi
lipoyl
novosphingobium
protein
includ
bacteri
homolog
mitochondri
enzym
major
pbc
antigen
fact
seroposit
novosphingobium
found
seroneg
pbc
patient
therefor
close
associ
diseas
presenc
antibodi
seroposit
novosphingobium
highli
specif
pbc
found
healthi
subject
diseas
although
antibodi
reflect
hallmark
pbc
role
pathogenesi
pbc
remain
unknown
autoimmun
diseas
establish
associ
titer
severityprogress
diseas
current
investig
role
b
cell
antibodi
mous
model
novosphingobiumsphingomona
found
mucos
surfac
part
bacteri
flora
gut
bacteri
transloc
may
occur
genet
predisposit
may
predispos
transloc
therefor
genet
suscept
may
reflect
predisposit
individu
develop
respons
self
also
inabl
prevent
system
infect
gramneg
bacterium
caus
appar
clinic
symptom
otherwis
healthi
sever
immunocompromis
individu
due
lack
lp
infect
novosphingobium
may
therefor
remain
undetect
subsequ
studi
need
analyz
port
bacteri
entri
intestin
liver
possibl
altern
ascend
bile
duct
infect
barrier
defect
allow
bacteria
access
bloodstream
subsequ
liver
base
clinic
report
establish
model
infect
mice
novosphingobium
induc
igg
respons
liver
lesion
resembl
pbc
human
figur
onset
sever
liver
diseas
model
depend
mous
genet
background
hepat
persist
novosphingobium
hepat
presenc
nkt
cell
activ
novosphingobium
gsl
greater
persist
novosphingobium
liver
organ
activ
nkt
cell
particularli
abund
liver
mice
novosphingobium
gsl
explain
liverspecif
patholog
therefor
model
unleash
mechan
organspecif
develop
auto
immun
respons
ubiquit
express
antigen
also
reflect
situat
human
character
redistribut
nkt
cell
blood
liver
contrast
mani
diseas
model
infectiontrigg
autoimmun
ectop
express
host
antigen
pathogen
andor
mous
requir
anim
system
induct
autoimmun
model
strictli
depend
bacteri
persist
chronic
infect
could
induc
inject
heatkil
bacteria
alon
select
applic
antibiot
eg
ampicillin
streptomycin
earli
stage
also
abolish
develop
liver
lesion
longterm
autoimmun
although
persist
bacteri
infect
critic
induct
fullblown
autoimmun
mous
model
initi
stage
diseas
liver
lesion
persist
even
advanc
bacteri
clearanc
suggest
autoimmun
compon
diseas
establish
mous
model
liver
lesion
adopt
transfer
convent
cell
wildtyp
nktdefici
mice
chronic
phase
illustr
import
earli
microbi
activ
nkt
cell
initi
autonom
organspecif
autoimmun
howev
antigen
cell
react
unknown
need
evalu
figur
nkt
cell
also
provid
help
b
cell
indic
reduc
igg
titer
nktcelldefici
mice
interestingli
direct
cognat
interact
nkt
b
cell
requir
produc
particular
respons
subclass
autoantibodi
consid
pathogen
futur
studi
need
evalu
role
b
cell
autoantibodi
pathogenesi
liver
diseas
use
bcell
deplet
approach
adopt
transfer
studi
although
data
suggest
molecular
mimicri
may
initi
diseas
figur
addit
studi
need
perform
confirm
hypothesi
result
diabet
model
suggest
diseas
acceler
initi
due
molecular
mimicri
howev
uniqu
innat
signal
associ
novosphingobium
infect
may
promot
expans
b
cell
may
even
present
low
frequenc
nkt
cellpromot
help
coadminist
protein
antigen
wellestablish
concept
observ
pbc
might
trigger
intestin
alphaproteobacterium
open
new
rout
possibl
treat
diagnos
devast
diseas
activ
nkt
cell
novosphingobium
gsl
liver
nkt
cell
abund
novosphingobium
persist
explain
organspecif
break
toler
ubiquit
autoantigen
liverspecif
patholog
pbc
translat
observ
may
reflect
basic
pathogen
mechan
pbc
patient
display
strike
redistribut
nkt
cell
blood
liver
may
provok
latent
infect
novosphingobium
contin
trigger
nkt
cell
activ
therefor
sign
infect
need
care
examin
may
immedi
appar
elev
biliari
alkalin
phosphatas
may
exampl
reflect
mechan
defend
bacteria
andor
detoxifi
bacteri
compon
shown
intestin
isoform
tissu
specimen
especi
liver
biopsi
pbc
patient
need
analyz
presenc
bacteria
rrnaspecif
qpcr
also
differ
time
point
particular
patient
earli
diseas
stage
need
identifi
bacteri
infect
may
clear
time
overt
diseas
indic
mous
model
antibodi
gener
preced
onset
liver
lesion
pbc
patient
may
reflect
onset
antibacteri
immun
respons
may
suitabl
time
window
appli
antibiot
howev
prove
presenc
bacteri
infect
bacteri
screen
test
need
develop
show
crossreact
sera
bacteri
antigen
also
bacteri
structur
crossreact
suggest
previou
studi
human
well
mous
model
use
elisa
screen
bacteri
flagellin
earli
stage
may
provid
use
tool
respect
clinic
test
help
identifi
crossreact
bacteri
antigen
correl
persist
bacteri
infect
defin
timefram
applic
antibiot
might
use
treatment
diseas
given
emerg
role
microbi
pathogen
autoimmun
diseas
defin
control
regul
host
immun
respons
improv
understand
pathogen
mechan
disord
respons
preced
develop
liver
lesion
report
even
two
decad
advanc
presenc
antibodi
serum
might
good
indic
administr
antibiot
patient
howev
prescreen
test
would
necessari
patient
gener
present
stage
diseas
liver
lesion
alreadi
present
although
consid
pbc
infecti
diseas
persist
bacteri
infect
may
drive
earli
stage
andor
initi
diseas
data
obtain
mous
model
togeth
clinic
data
pbc
patient
strongli
impli
possibl
suggest
intens
prescreen
patient
risk
exampl
famili
member
carri
antibiot
administr
especi
secret
bile
like
antibiot
ampicillin
consid
clinic
asymptomat
patient
exhibit
respons
reactiv
novosphingobium
antigen
howev
resist
profil
individu
situat
includ
treatment
option
consid
choic
respect
antibiot
discoveri
infecti
trigger
autoimmun
elucid
mechan
induc
tissu
damag
chang
current
concept
etiolog
variou
autoimmun
syndrom
may
suggest
new
simpler
way
diagnos
treat
debilit
diseas
mitochondria
phylogenet
closest
relat
alphaproteobacteria
like
due
evolut
mitochondria
alphaproteobacteria
novosphingobium
spp
within
class
alphaproteobacteria
strongli
associ
pathogenesi
primari
biliari
cirrhosi
pbc
sera
patient
pbc
recogn
mammalian
also
crossreact
homologu
share
novosphingobium
spp
anim
model
establish
novosphingobium
infect
induc
pbclike
liver
lesion
respons
reflect
situat
human
provid
experiment
proofofprincipl
studi
model
suggest
applic
antibiot
may
treatment
option
especi
earli
stage
diseas
antibodi
preced
onset
clinic
symptom
liver
patholog
pbc
patient
may
reflect
onset
antibacteri
immun
respons
may
suitabl
time
window
applic
antibiot
test
sera
pbc
patient
reactiv
addit
novosphingobium
antigen
exampl
flagellin
may
provid
clinic
indic
initi
antibiot
therapi
antibiot
secret
bile
preferenti
use
